Derek Borkowski, PharmD

pharmacist && software engineer | founder/ceo @PyrlsApp 🔮 @ycombinator W22

[Jonathan Adly @Jonathan_Adly_]

I am soft launching ColiVara today 🧵

A state of the art retrieval API that is a web-first implementation of the ColiPali paper.

It works exactly like RAG from the end-user standpoint - but using vision models instead of chunking and text-processing for documents.

[Andi @andi_search]

Andi ranks #1 on a new SOTA AI search benchmark. Here's how we did it with just $3M in funding 🚀

[MedEd101 @Mededucation101]

The ADA Guidelines are updated each year: What should you know about the 2024 recommendations? https://t.co/Mi4WVoUq5O #pharmacy #meded #pyrls #diabetes

[Pyrls @PyrlsApp]

We're excited to feature Hunter Rondeau (@Floralquinolone) in this week's #TeamTuesday! ✨

Hunter is an Antimicrobial Stewardship Coordinator at SSM Health. He completed his PGY2 in infectious diseases at M Health Fairview University of Minnesota Medical Center (Minneapolis, MN), his PGY1 training at UF Health Shands Hospital (Gainesville, FL), and is a Doctor of Pharmacy graduate from the KU School of Pharmacy.

Learn more about Hunter, who we're grateful to work with on team Pyrls! 🔮

[stein💊 @stein_writes]

Good evening, TL.
I'm thrilled to share with you my opinion piece on the topic 'Antimicrobial Resistance in African slums' which was recently published on Global Health Unfiltered. The topic was inspired by Professor Folasade Ogunsola, Vice Chancellor, University of Lagos,..

[Hunter O. Rondeau @Floralquinolone]

Thank you for the opportunity @PyrlsApp! I hope this piece empowers clinicians to shift from the goal of a "perfect" trough for all, to a patient that truly would benefit from vancomycin TDM. #IDTwitter #TwitteRx #MedTwitter #IDXposts

[Pyrls @PyrlsApp]

2024 Inhaler Products Chart ✨

FREE PDF in your @PyrlsApp and website!

See what's included 👇😊

[Pyrls @PyrlsApp]

The 2024 American Diabetes Association Standards of Care in Diabetes are here! ✨

We've updated our free chart and content throughout the @PyrlsApp reflect the latest in type 2 diabetes pharmacotherapy!

[Derek Borkowski, PharmD @derek7ski]

Okay this is officially the new most fun I've had with this.

NOTE: Experimental purposes only!

Made a bot that takes an image of a med list (NOTE: this is a dummy med list from google) and automatically:

1. Scrapes and makes a list of the medications it finds in the image
2. Lists potential drug interactions it sees between them
3. Lists potential renal and hepatic dosing considerations amongst the meds it sees

To be clear, it's very poorly tuned right now and how well tuned it ultimately could be is in question but super interesting glimpse to what could be...

Also fun that I can use it on my ChatGPT phone app with images from camera.
https://t.co/eARCVm2CuL

[Pyrls @PyrlsApp]

NEW ✨ Obesity Pharmacotherapy Resources in your @PyrlsApp!

- NEW: Obesity Pharmacotherapy Chart & Review 📊
- NEW: Anti-Obesity Medication Summaries 💊
- Updated: Obesity Knowledge Check Quiz  ✅

[Derek Borkowski, PharmD @derek7ski]

@ConanMacDougall @KatherineGberg Likewise a little clunky revision-suggestion outputs (which I'll take the blame for 😅) so trying to keep workshopping the prompting on this to make the outputs practical to apply to my writing!

[Derek Borkowski, PharmD @derek7ski]

@ConanMacDougall @KatherineGberg Thanks so much for the inspiration!... Finally getting a chance to play around with this. Definitely think there's tons of promise in teaching and education—currently playing around with something to help improve medical writing... https://t.co/yKh1DmBJIk

[Pyrls @PyrlsApp]

Tirzepatide (ZEPBOUND) Approved for Chronic Weight Management in Adults with Obesity ✨

The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or greater or overweight (BMI of 27 kg/m2 or greater) with at least one weight-related condition (such as HTN, T2DM or high cholesterol) for use, in addition to a reduced calorie diet and increased physical activity.

Tirzepatide is already approved under the trade name Mounjaro for glycemic control in adults with type 2 diabetes mellitus.

[Pyrls @PyrlsApp]

Diabetes Drug Classes Comparison 📊

FREE chart in your @PyrlsApp 📱

#Diabetes #TwitteRx #MedTwitter

[Derek Borkowski, PharmD @derek7ski]

@MedFactChecks @reverendofdoubt @PyrlsApp Yeah we sourced this pretty close to the 2016 guidelines and did add some footnotes to try to capture the existing and more recent nuance on double coverage and newer agents. Really appreciate your clinical practice perspectives!

[Pyrls @PyrlsApp]

Hospital-Acquired Pneumonia Pharmacotherapy 🏥

Free chart PDF in your @PyrlsApp! ✨

#IDTwitter #TwitteRx #MedTwitter

[Derek Borkowski, PharmD @derek7ski]

@Austen It actually is available in pill form under brand name Rybelsus so you can stand your ground! 🤓 (it’s just not nearly as potent)